Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IMMUNOCORE HOLDINGS PLC

(IMCR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Immunocore Holdings plc
Immunocore Holdings plc, formerly Immunocore Holdings Ltd, is a late-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies called Immune mobilizing monoclonal TCRs Against X disease (ImmTAX) designed to treat diseases, including cancer, infectious and autoimmune. The Company is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. The CompanyÔÇÖs pipeline is leveraging ImmTAX platform within three therapeutic areas: oncology, infectious disease and autoimmune disease.
Sales per Business
20192020Delta
Genentech24.3674.4%25.9567.2% +6.51%
GlaxoSmithKline7.3422.4%8.1521.1% +11.05%
Eli Lilly1.043.2%4.5211.7% +332.27%
USD in Million
Sales per region
20192020Delta
United States25.4177.6%30.4778.9% +19.91%
United Kingdom7.3422.4%8.1521.1% +11.05%
USD in Million
Managers
Name Title Age Since
Bahija Jallal, Dr. Chief Executive Officer & Director 58 2019
Brian R. DiDonato Chief Financial Officer & Head-Strategy 53 2020
David Berman, Dr. Head-Research & Development - 2019
Roy Steven Herbst, Dr. Non-Executive Director 57 2021
Ralph Torbay Head-Commercial - 2021
Members of the board
Name Title Age Since
Bahija Jallal, Dr. Chief Executive Officer & Director 58 2019
John Irving Bell, Dr. Non-Executive Director 69 2015
Travis Coy Non-Executive Director - 2019
Robert J. Perez Non-Executive Director 56 2019
Kristine Peterson Non-Executive Director 60 2017
Roy Steven Herbst, Dr. Non-Executive Director 57 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 44,617,715 32,762,844 73.4% 0 0.0% 73.4%
Shareholders
NameEquities%
Baker Bros. Advisors LP 2,520,730 5.87%
Rock Springs Capital Management LP 2,445,155 5.69%
Fidelity Management & Research Co. LLC 1,750,074 4.07%
RTW Investments LP 1,245,532 2.90%
Avidity Partners Management LP 1,095,600 2.55%
Wellington Management Co. LLP 1,052,075 2.45%
General Atlantic LLC 950,000 2.21%
Bain Capital Public Equity LP 638,205 1.49%
Bill & Melinda Gates Foundation Trust (Investment Management) 576,923 1.34%
BlackRock Advisors LLC 572,791 1.33%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Immunocore Holdings plc
Sector Other Biotechnology & Medical Research